Entero Therapeutics, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 1 | -$0.77 | -$0.77 | -$0.77 |
| Q2 2024 | 1 | -$1.55 | -$1.55 | -$1.55 |
| Q3 2024 | 1 | -$0.32 | -$0.32 | -$0.32 |
| Q4 2024 | 1 | -$0.41 | -$0.41 | -$0.41 |
Entero Therapeutics, Inc. Earnings Date And Information
Entero Therapeutics, Inc. last posted its earnings results on Monday, November 11th, 2024. The company reported $-3.37 earnings per share for the quarter, missing analysts' consensus estimates of $-0.32 by $3.05. The company had revenue of 0 for the quarter and had revenue of 0 for the year. Entero Therapeutics, Inc. has generated $-48 earnings per share over the last year ($-47.88 diluted earnings per share) and currently has a price-to-earnings ratio of -0.21. Entero Therapeutics, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, February 26th, 2025 based on prior year's report dates.
Entero Therapeutics, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 09/30/2024 | Q3 2024 | -$1.55 | -$0.59 | 0.96 | $0 | $0 |
| 06/28/2024 | Q2 2024 | -$3.86 | $0 | $0 | ||
| 03/30/2024 | Q1 2024 | $3.12 | $0 | $0 | ||
| 12/30/2023 | Q4 2023 | -$2.68 | $0 | |||
| 09/29/2023 | Q3 2023 | -$9.21 | $0 | |||
| 06/29/2023 | Q2 2023 | -$37.73 | $0 | |||
| 03/30/2023 | Q1 2023 | -$36.46 | $0 | |||
| 12/30/2022 | Q4 2022 | -$80.08 | $0 | |||
| 09/29/2022 | Q3 2022 | $370.13 | $-4,430 | $0 | ||
| 06/29/2022 | Q2 2022 | -$1,069.40 | $0 | |||
| 03/30/2022 | Q1 2022 | -$2,786.36 | $-7,000 | $0 | ||
| 12/30/2021 | Q4 2021 | -$3,191.50 | $0 | |||
| 09/29/2021 | Q3 2021 | -$13,720.00 | $0 | |||
| 06/29/2021 | Q2 2021 | -$6,843.48 | $0 | |||
| 03/30/2021 | Q1 2021 | -$22,750.00 | $0 | |||
| 12/30/2020 | Q4 2020 | -$26,281.00 | $0 | |||
| 09/29/2020 | Q3 2020 | -$19,836.00 | $0 | |||
| 06/29/2020 | Q2 2020 | -$7,039.62 | $0 | |||
| 03/30/2020 | Q1 2020 | -$8,201.76 | $0 | |||
| 12/30/2019 | Q4 2019 | -$2,008.44 | $0 |
Entero Therapeutics, Inc. Earnings: Frequently Asked Questions
-
When is Entero Therapeutics, Inc.'s earnings date?
Entero Therapeutics, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, February 26th, 2025 based off last year's report dates.
-
How can I listen to Entero Therapeutics, Inc.'s earnings conference call?
The conference call for Entero Therapeutics, Inc.'s latest earnings report can be listened to online.
-
How can I read Entero Therapeutics, Inc.'s conference call transcript?
The conference call transcript for Entero Therapeutics, Inc.'s latest earnings report can be read online.
-
How much profit does Entero Therapeutics, Inc. generate each year?
Entero Therapeutics, Inc. (:ENTO) has a recorded net income of $0. Entero Therapeutics, Inc. has generated $-47.88 earnings per share over the last four quarters.
-
What is Entero Therapeutics, Inc.'s price-to-earnings ratio?
Entero Therapeutics, Inc. (:ENTO) has a price-to-earnings ratio of -0.21 and price/earnings-to-growth ratio is -0.
